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HYPERPOLARIZED CARDIAC 
ARREST WITH A 
POTASSIUM-CHANNEL 
OPENER, APRIKALIM 
Cardioplegic solutions that arrest the heart at or near the resting mem- 
brane potential may provide better myocardial protection than standard 
depolarizing hyperkalemic ardioplegia by reducing both metabolic de- 
mand and harmful transmembrane ion fluxes. This hypothesis was inves- 
tigated in an isolated, blood-perfused, rabbit heart Langendorff model 
during 30 minutes of normothermic global ischemia. Hyperpolarized 
cardiac arrest induced by aprikalim, an opener of adenosine triphosphate- 
dependent potassium channels, was compared with hyperkalemic depolar- 
ized arrest and with unprotected global ischemia. Left ventricular pressure 
was recorded over a wide range of balloon volumes before ischemia nd 30 
minutes after reperfnsion. End-diastolic pressure versus balloon volume 
data were fitted to a two-coefficient exponential relationship. Changes in 
the diastolic ompliance of the left ventricle were assessed by comparison of 
preischemic and postischemic coefficients within each cardioplegia group. 
Postischemic recovery of developed pressure was used to assess changes in 
left ventricular systolic function. The tissue water content of each heart was 
also determined. Myocardial protection with aprikalim resulted in better 
postischemic recovery of developed pressure (90% - 9%) than either 
protection with hyperkalemic cardioplegia (73% +_ 11%) or no protection 
(62% - 9%). Myocardial tissue water content in hearts protected with 
hyperkalemic cardioplegia (77.4% -+ 1.4%) was less than the tissue water 
content of either unprotected hearts (79.4% -+ 1.2%) or hearts protected 
with aprikalim (78.7% -+ 0.9%). Despite these differences, neither hy- 
perkalemic ardioplegia (p = 0.15) nor aprikalim cardioplegia (p = 0.30) 
was associated with a significant postischemic decrease in ventricular 
compliance. By contrast, unprotected global ischemia was associated with a 
significant decrease in ventricular compliance (p < 0.001). (J THORAC 
CARDIOVASC SURG 1995;110:1083-95) 
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T he goal of myocardial protection strategies used during elective cardiac arrest is the rapid induc- 
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nance of the myocardium in a state of minimal 
metabolic requirement)  Most current echniques of 
myocardial preservation use hyperkalemic solutions 
to achieve a rapid electromechanical standstill) 
However, numerous detrimental consequences are 
associated with the membrane depolarization 
caused by hyperkalemic ardioplegia. 2-4 Abnormal 
intracellular accumulation of specific ions at depo- 
larized membrane potentials can have deleterious 
physiologic effects. Progressive membrane depolar- 
ization results in a spontaneous influx of sodium that 
is manifested as the sodium "window current. ''5' 6 
Intracellular calcium accumulation results from the 
exchange of intracellular sodium for extracellular 
calcium via the Na+-Ca +2 exchanger. 5" 6 There also 
is a concomitant influx of calcium through the 
calcium "window current" and leakage of calcium 
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from the sarcoplasmic reticulum. 6'7 The resultant 
myocardial calcium overload has been implicated in 
ischemia/reperfusion injury and myocardial stun- 
ning, particularly after surgical global ischemia dur- 
ing depolarized cardiac arrest. 2-4 These ion fluxes 
also impose a metabolic burden on the myocyte by 
providing substrate for the activation of the energy- 
dependent ion pumps, including the sarcolemmal 
sodium-potassium and calcium adenosinetriphos- 
phatases (ATPases). 3
At the normal resting membrane potential of the 
myocyte net intracellular ion flux is minimal because 
the transmembrane ion concentration gradients are 
largely balanced and few voltage-gated ion channels 
are open. 8 Consequently, energy-dependent ion 
pump activity, and thus metabolic demand, is mini- 
mal. The feasibility of maintaining the membrane 
potential of the myocyte at or near the normal 
resting membrane potential during global ischemia 
(termed hyperpolarized cardiac arrest) has been doc- 
umented previously. 9-11 Hyperpolarized cardiac ar- 
rest may be more cardioprotective than depolarized 
arrest, both by optimizing the metabolic state of the 
myocardium and by avoiding the injurious ion fluxes 
that occur during depolarized arrestJ 2' 13 
Previously, our laboratory has demonstrated the 
feasibility of hyperpolarized cardiac arrest induced 
by aprikalim, an agent that selectively opens ATP- 
dependent potassium channels (KATP channels). 14 
The opening of myocardial KAT P channels activates 
an outward potassium current that results in cell 
membrane hyperpolarization a d a dramatic short- 
ening of the action potential duration. 15 This de- 
crease in the action potential duration and the 
accompanying decrease in the plateau phase of the 
action potential lead to a reduction in calcium influx 
and ultimately to contractile failure. TM 16. 17 Numer- 
ous studies have documented the cardioprotective 
effects of potassium-channel openers, under both 
globally14. 17 and regionally 18' 19 ischemic myocardial 
conditions. The administration of potassium-chan- 
nel openers has also been shown to ameliorate 
myocardial stunning. 2°' 21 Furthermore, opening of 
the KAa-p channel has been implicated in the mech- 
anism of ischemic preconditioning. 22'23 
Previous work from our laboratory has used phar- 
macologic dosages of aprikalim (RP 52891, Rhone- 
Poulenc Rorer, Antony, France) to produce hyper- 
polarized cardiac arrest during normothermic global 
ischemia in a Krebs-Henseleit solution-perfused 
rabbit heart Langendorff model. 14 In this model, 
postischemic recovery of developed pressure in 
hearts protected with aprikalim was greater than 
recovery in hearts protected with hyperkalemic car- 
dioplegia. 14 However, crystalloid perfusate has sig- 
nificant drawbacks that make it a less suitable 
medium for the investigation of ischemia/reperfu- 
sion injury. Specific adverse effects attributed to 
crystalloid perfusate include increased myocardial 
edema formation, z4a decreased capacity to buffer 
myocardial tissue pH, 25-27 exacerbation of ischemia/ 
reperfusion injury, z8 and potentially adverse pat- 
terns of perfusate rheology. 27' 29 These problems 
raise questions about the clinical relevance of crys- 
talloid-perfused models of ischemia/reperfusion n- 
jury. To address this issue, the abilities of hyperpo- 
larizing aprikalim cardioplegia nd hyperkalemic, 
depolarizing cardioplegia to protect the myocar- 
dium during normothermic, global ischemia were 
compared in a more clinically relevant, blood-per- 
fused, parabiotic rabbit heart Langendorff model. 
Methods 
Adult New Zealand White rabbits of either sex, weigh- 
ing 3 to 4 kg, were used in this study. All animals received 
humane care in compliance with the "Principles of Lab- 
oratory Animal Care" formulated by the National Society 
for Medical Research and the "Guide for the Care and 
Use of Laboratory Animals" prepared by the Institute of 
Laboratory Animal Resources and published by the Na- 
tional Institutes of Health (NIH Publication No. 86-23, 
revised 1985). 
Experimental preparation 
Preparation of the support animal. The support rabbit 
was anesthetized byintramuscular injection of aceproma- 
zine (1 mg/kg), xylazine (5 mg/kg), and ketamine (40 
mg/kg). The level of anesthesia was monitored continu- 
ously and was supplemented as needed. 
A tracheostomy was performed, an endotracheal tube 
inserted, and mechanical ventilation begun with 100% 
oxygen (ventilator model 683, Harvard Apparatus, Dover, 
Mass.). Serial arterial blood gas determinations were 
made and ventilator settings were adjusted to maintain 
arterial pH between 7.3 and 7.5, carbon dioxide tension 
between 35 and 45 torr, and oxygen tension greater than 
200 torr. Heparin (2500 U) was given through an ear vein. 
The right femoral artery was cannulated and continuous 
invasive monitoring of blood pressure was begun. A mean 
arterial pressure of 60 mm Hg was maintained by trans- 
fusion of blood or infusion of Plasma-Lyte solution (in 
millimoles per liter: Na 140, K 5, Mg 3, C1 98, acetate 27, 
gluconate 23) as dictated by the results of serial hemato- 
crit determinations. Blood for transfusion was obtained at 
the time of cardiectomy from the thoracic avity of the 
rabbit providing the isolated heart. 
The left internal jugular vein and the left carotid artery 
were cannulated. An extracorporeal circuit was estab- 
lished by continuous withdrawal of blood from the carotid 
artery cannula (Fig. 1). The blood was pumped to an 
80 cm high modified Langendorff perfusion column. Ef- 
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Fig. 1. Isovolumic, blood-perfused, parabiotic, isolated rabbit heart Langendorff model. 
fluent blood from the Langendorff apparatus was rein- 
fused into the support rabbit via the venous cannula, thus 
completing the circuit. Indomethacin (1 mg/kg) was ad- 
ministered to the support rabbit to maintain stability of 
the preparation. 3°
Preparation of the isolated heart. The rabbit providing 
the isolated heart was anesthetized, intubated, placed on 
ventilator support, and heparinized in an identical manner 
to that used in the support rabbit. The heart was excised 
through a median sternotomy and the blood that drained 
into the thoracic cavity was collected for transfusion into 
the support rabbit. The aorta was cannulated and the 
heart was suspended from a modified Langendorff appa- 
ratus (Fig. 1). Retrograde aortic perfusion with support- 
animal blood from the column was instituted. Perfusate, 
bath, and myocardial temperatures were monitored con- 
tinuously with thermocouples (model DP29-0031-001A, 
Shiley, Inc., Irvine, Calif.). The column and bath water- 
jacket emperatures were adjusted to maintain myocardial 
temperature between 37.0°C and 37.5° C (model 9010, 
Fisher Scientific, Pittsburgh, Pa.). 
A latex balloon was placed through the mitral valve into 
the left ventricle. The balloon was secured in place with a 
purse-string suture in the mitral valve anulus. The balloon 
was connected via fluid-filled polyethylene tubing to a 
pressure transducer (model P231D, Gould, Cleveland, 
Ohio) and amplifier (Gould model 13-4615-50). The zero 
pressure reference was set at the level of the aortic valve. 
The pressure waveform was digitized on-line at a sampling 
rate of 1000 Hz (AT-CODAS, DATAQ Instruments, 
Akron, Ohio) and displayed on a personal computer 
(Z-386/20, Zenith, Glenview, Ill.). 
Two needle electrodes (Grass Instruments, Quincy, 
Mass.) were fixed to the right atrial appendage to atrially 
pace the heart using a pulse generator (model 5320, 
Medtronic, Inc., Minneapolis, Minn.). Two additional 
Grass electrodes were applied to the epicardium of the 
left ventricular free wall to monitor a bipolar ventricular 
electrogram. The electrogram signal was boosted with an 
isolated preamplifier (Gould model 11-G5407-58), which 
was connected to a universal amplifier (Gould model 
13-4615-58) and filtered with a low pass frequency of 0.05 
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Hz and a high pass frequency of 1 kHz. The electrograms 
were digitized at a sampling rate of 1000 Hz and displayed 
in real time on the Zenith computer. 
Experimental protocol. After instrumentation, the 
heart was allowed to recover until stable end-diastolic and 
peak systolic left ventricular pressures were established 
(20 to 30 minutes). Control data were acquired. Intracav- 
itary left ventricular pressure waveforms and left ventric- 
ular bipolar electrograms were recorded over a range of 
nine balloon volumes corresponding to nine randomly 
ordered left ventricular end-diastolic pressures (0, 2.5, 5, 
7.5, 10, 12.5, 15, 20, and 25 mm Hg) at a fixed, paced rate 
of 150 to 180 beats/min. The analog signals were recorded 
on VHS videotape with a tape recorder (TEAC model 
XR-70, Tokyo, Japan) and also were digitized on-line for 
subsequent analysis. 
After control data acquisition, hearts were randomized 
to receive one of three types of myocardial protection 
concomitant with the onset of a 30-minute period of 
normothermic, global, surgical ischemia: (1) no cardiople- 
gia (control group), (2) depolarizing cardioplegia, or (3) 
hyperpolarizing cardioplegia. The retrograde perfusion 
column was clamped and either 40 ml of normothermic 
cardioplegic solution was delivered into the aortic root via 
a separate 80 cm perfusion column (hyperpolarizing or 
depolarizing cardioplegia groups) or no cardioplegic so- 
lution was delivered (control group). Depolarizing car- 
dioplegic solution was made by adding a sufficient quantity 
of potassium chloride to Krebs-Henseleit solution (in 
millimoles per liter: NaC1 118.5, NaHCO 3 25, KC1 3.2, 
KH2PO 4 1.2, MgSO 4 1.2, CaC12 2.5, and glucose 5.5) to 
obtain a final potassium ion concentration of 20 mmol/L. 
Hyperpolarizing cardioplegic solution was made by add- 
ing aprikalim (RP 52891) to the Krebs-Henseleit solution. 
The aprikalim concentration used was 100 tzmol/L. This 
was previously shown to be the concentration that maxi- 
mized the percentage recovery of developed pressure 
after 20 minutes of global ischemia in a Krebs-Henseleit 
solution-perfused isolated rabbit heart Langendorff mod- 
el. TM The difference in osmolality between the cardioplegic 
solutions was eliminated by the addition of a sufficient 
quantity of sucrose to the hyperpolarizing cardioplegic 
solution to bring its osmolality into the 305 to 310 
mOsm/kg range as measured by a freezing-point depres- 
sion osmometer (Osmette A model 5002, Precision Sys- 
tems, Inc., Natick, Mass.). 
After 30 minutes of global ischemia, the perfusion 
column was unclamped and the heart was reperfused with 
support animal blood. Postreperfusion data were col- 
lected after 30 minutes of reperfusion. Intracavitary left 
ventricular pressure waveforms and left ventricular bipo- 
lar electrograms were recorded over a range of nine 
randomly ordered balloon volumes at the identical paced 
rate used during control data acquisition. Balloon vol- 
umes were identical to those used during control data 
acquisition when feasible. When left ventricular compli- 
ance changes precluded this, the number of matching 
volumes examined was maximized. However, a left ven- 
tricular end-diastolic pressure of 40 mm Hg was not 
exceeded. After postreperfusion data were acquired, a 
portion of the left ventricular myocardium was excised, 
weighed, and then dried in a 70 ° C oven until a constant 
dry weight was reached. Tissue water percentage was 
expressed as the difference between wet and dry weights 
of the sample divided by the wet weight of the sample. 
Data analysis. Computer software was developed to 
standardize the analysis of the digitized pressure wave- 
forms. 
End-systolic pressure. The end-systolic pressure (ESP) 
of a beat was defined as the maximum of the three-point 
moving average of the digitized pressure waveform. The 
average ESP was calculated by averaging the ESP values 
of 10 consecutive beats. Average ESP values were ob- 
tained in this manner for each of the 18 (9 control and 9 
postreperfusion) balloon volumes (Vol). The ESP versus 
balloon volume data were fitted to a linear ESP-volume 
relationship (ESPVR) (equation 1), with a least-squares 
linear regression algorithm. 
ESP = Ema x × Vol + K (1) 
where Em~ is the slope of the linear ESPVR and K is the 
Y-axis intercept of the linear ESPVR. Control slope 
(E . . . .  ) and intercept (K~) were obtained from the con- 
trol ESP-volume data. Postreperfusion slope (E~- r )  
and intercept (Kpr) were obtained from the postreper-~:u- 
sion ESP-volume data. 
End-diastolic pressure. The end-diastolic pressure 
(EDP) of a beat was defined as the pressure at which the 
first derivative of the digitized pressure waveform with 
respect to time first exceeded 0.25 mm Hg/msec. The 
instantaneous first derivative of the digitized pressure 
waveform with respect o time was approximated from 
the pressure waveforms digitized at a sampling rate of 1 
kHz. Its value at any particular time was defined as the 
slope of the line obtained by a linear least-squares 
regression of five consecutive pressures centered about 
that particular time. The average EDP was calculated 
by averaging the EDP values of 10 consecutive beats. 
Average EDP values were obtained in this manner for 
each of the 18 (9 control and 9 postreperfusion) balloon 
volumes (Vol). The EDP versus balloon volume data 
were fitted to a simple exponential EDP-volume rela- 
tionship (EDPVR)31(equation 2), with a least-squares 
nonlinear egression algorithm. 
EDP = a x e ~ x v°l (2) 
where a and /3 are the nonlinear coefficients of the 
exponential EDP-volume relationship and e is the base of 
natural logarithms. Control a (%) and /3 (/3c) were 
obtained from the control EDP-volume data. Postreper- 
fusion ~x (O~pr) and /3 (/3pr) were  obtained from the 
postreperfusion EDP-volume data. 
Developed pressure. Developed pressure was defined 
as the difference between the ESP and EDP. The 
average developed pressure was calculated by averaging 
the developed pressure values of 10 consecutive beats. 
Average developed pressure values were obtained in 
this manner for each of the 18 (9 control and 9 
postreperfusion) balloon volumes (Vol). The developed 
pressure (DP) versus balloon volume data were fitted to 
a nonlinear developed pressure-volume relationship 
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Table I. Mechan ica l  and  e lectr ica l  parameters  
Solution delivery Electrical 
Cardioplegia n time (sec) DPlo % (sec) DPo% (sec) asystole (sec) V-fib (%) 
None 8 - -  161 -- 40* 387 ± 113 1661 ± 297 13 
KCI 8 97 -- 37 36 4- 14t 47 ± 141" 51 ± 20# 0 
Apr ika l im 8 100 _+ 15 193 -4- 29 281 -- 25:~ 890 ± 517:~ 38 
DPloo/o Length of time for developed pressure to fall to 10% of its preischemic value; DPo~o length of time for developed pressure to fall to less than 1% 
of its preischemic value; electrical systole, length of time for electrical quiescence to develop for KC1 and aprikalim groups and length of time that electrical 
activity persisted for the unprotected heart group because lectrical quiescence was not achieved in six out of the eight hearts in this group; V-fib, percentage 
of hearts sustaining ventricular fibrillation on reperfusion. 
*p < 0.05 versus Aprikalim. 
tp < 0.05 versus None, Aprikalim. 
< 0.05 versus None. 
(equation 3), obtained by subtracting equation 2 from 
equation 1. 
DP= 
ESP  - EDP  = Emax X Vol + K - a X e ~ x Vol 
(3) 
Control developed pressure-volume data were fitted us- 
ing the values of E . . . .  and K~ (determined by linear 
regression of the control ESP-volume data) and ac and/3 c
(determined by nonlinear egression of the control EDP- 
volume data) to equation 4. Postreperfusion developed 
pressure-volume data were fitted using the values of 
Emax_pr and Kpr and O~pr and /3pr to equation 5. 
DP = E . . . .  X Vol + Kc -ac  X e ~xv°t  (4) 
DP = Emax.pr X Vol + Kpr  - Otpr X e ~,r × Vot (5) 
Post ischemic recovery o f  developed pressure. The post- 
ischemic recovery of developed pressure (%Recov) was 
calculated as the ratio of the postreperfusion average 
developed pressure to the control average developed 
pressure at the same balloon volume, expressed as a 
percentage. Percentage r coveries were obtained in this 
manner for each of the nine postreperfusion balloon 
volumes that had an identically matching control bal- 
loon volume. The percentage recovery of developed 
pressure versus balloon volume data were fitted to a 
nonlinear elationship (equation 6), obtained by divid- 
ing equation 5 by equation 4 using the previously 
determined values of E . . . . . .  Emax_pr, Kc, Kpr, oLc, O/pr, ~c, 
and flpr' 
% Recov  = 
100 x 
Em.x-pr × Vol + Kpr - %r × e ~' x Vot 
E . . . .  x Vol + Kc - ac X e t~ × vot (6) 
The average postischemic percentage recovery of de- 
veloped pressure (Avg % Recov) was defined as the 
average value of the postischemic recovery of devel- 
oped pressure function (equation 6) over the relevant 
balloon volume range and was formally calculated by 
equation 7. 
Avg % Recov = 
fvfEmax.pr X Vol + Kpr  - Olpr X e ~" x rot 
100 × E . . . .  x Vol + Kc % x e ~ × rot dVo l  
a 
vb-v .  
(7) 
where Vb is the maximum postreperfusion balloon volume 
and Va is the minimum postreperfusion balloon volume. 
Because the integrand in equation 7 cannot be formally 
integrated, the value of the definite integral was approxi- 
mated by a numeric method (trapezoidal rule). 
Statistical analysis. All cumulative results are ex- 
pressed as the mean plus or minus the standard eviation. 
Analysis of variance was used for multiple comparisons. 
When either the equal variance criterion or normality 
criterion was not satisfied, the Kruskal-Wallis analysis of 
variance on ranks was used as a nonparametric alterna- 
tive. When a significant F value was obtained, comparison 
between groups was made by a Student-Newman-Keuls 
post test. Preischemic a and/3 coefficients of the expo- 
nential eft ventricular EDP-balloon volume relationship 
were compared with the postischemic coefficients within 
each group by a method of multivariate analysis (Hotell- 
ing t 2 test) to determine whether ventricular compliance 
had changed. The X z test was used to compare propor- 
tions among multiple groups. 
A difference was considered statistically significant 
when p < 0.05. 
Results 
Temporal aspects of the development of electro- 
mechanical quiescence. Eight hearts were subjected 
to 30 minutes of unprotected, normothermic global 
ischemia. Developed pressure fell to 10% and 0% of 
its prearrest value at 161 _ 40 and 387 _+ 113 seconds, 
respectively, after the onset of isehemia (Table I). 
Electrical activity persisted throughout the 30-minute 
ischemic period in six of the eight hearts. 
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Fig. 2. EDPVR. Each data point represents mean EDP of 10 beats. Filled circles represent preischemic 
data; filled triangles represent data obtained 30 minutes after reperfusion. Error bars represent one standard 
deviation of mean. A, EDP at various balloon volumes in an unprotected heart. B, EDP at various balloon 
volumes in a heart protected with hyperpolarizing cardioplegia. 
Myocardial protection with hyperpolarizing car- 
dioplegic solution that contained aprikalim was 
studied in eight hearts. Immediately after the onset 
of global ischemia, the coronary arteries were per- 
fused with 40 ml of hyperpolarizing cardioplegic 
solution (Krebs-Henseleit solution containing 100 
/xmol/L aprikalim). Development of electrical and 
mechanical quiescence was significantly more rapid 
than in unprotected hearts (p < 0.05); however, 
myocardial protection with hyperkalemic depolariz- 
ing cardioplegic solution resulted in the most rapid 
onset of electrical and mechanical asystole (p < 
0.05) (Table I). With hyperkalemic ardioplegia, 
mechanical quiescence occurred six times faster and 
electrical quiescence occurred 17 times faster than 
with aprikalim cardioplegia. Delivery time for the 
hyperkalemic cardioplegic solution was not signifi- 
cantly different from the delivery time for aprikalim 
cardioplegic solution (p = 0.834). 
Reperfusion ventricular arrythmias. Three 
hearts protected with hyperpolarizing cardioplegia 
and a single unprotected heart sustained ventricular 
fibrillation on reperfusion and were electrically con- 
verted to sinus rhythm (Table I). The remaining 20 
hearts spontaneously achieved sinus rhythm after 
reperfusion. There was not a statistically significant 
difference in the occurrence of postreperfusion ven- 
tricular fibrillation among the three groups (p = 
0.122). 
Postischemic diastolic properties. Retrograde 
aortic perfusion was restored after 30 minutes of 
normothermic, global ischemia in all hearts. Balloon 
pressure rose from its preischemic value of 5 mm Hg 
in all hearts to 9 2 5 mm Hg in hearts protected with 
depolarizing cardioplegia, to 7 + 2 mm Hg in hearts 
protected with hyperpolarizing cardioplegia, and to 
14 _+ 4 mm Hg just before reperfusion in unpro- 
tected hearts Co < 0.05 versus depolarizing, hyper- 
polarizing cardioplegia). 
After 30 minutes of reperfusion, postischemic o~ 
and/3 coefficients of the exponential EDPVR (equa- 
tion 2) were determined for each heart. Fig. 2, A, 
shows control and postischemic EDPVR curves 
from a single unprotected heart. The relatively large 
leftward displacement of the postischemic urve 
with respect o the preischemic urve seen in this 
heart was typical of all hearts of this group. Fig. 2, B, 
shows control and postischemic EDPVR curves 
from a single heart protected with hyperpolarizing 
cardioplegia. Neither hyperpolarizing cardioplegia 
nor depolarizing cardioplegia resulted in significant 
displacement of the postischemic EDPVR curve. 
Bivariate analysis of the preischemic and postisch- 
emic o~ and /3 coefficients demonstrated that the 
postischemic oefficients were significantly higher 
(p < 0.001) than the preischemic oefficients in 
unprotected hearts, which indicated the occurrence 
of a significant postischemic decrease in ventricular 
compliance in this group. Ventricular compliance 
did not change significantly in hearts protected with 
either depolarizing cardioplegia (p = 0.15) or hy- 
perpolarizing cardioplegia (p = 0.30). 
Postischemic systolic function. After 30 minutes 
of normothermic, global ischemia nd 30 minutes of 
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reperfusion, ventricular systolic function was as- 
sessed in each heart. Postischemic Emax and K 
coefficients of the linear ESPVR (equation 1) were 
determined for each heart in each group. Fig. 3, .4, 
shows the control and postischemic ESPVR of a 
single unprotected heart. 
Developed pressure versus balloon volume data 
from each heart were fitted to a nonlinear elation- 
ship of the form of equation 3 using the values of the 
a and/3 coefficients determined from the EDPVR 
and the Ema x and K coefficients determined from the 
ESPVR. Fig. 3, B, shows the control and postisch- 
emic developed pressure-volume r lationship of a 
single unprotected heart. 
Percentage recovery of developed pressure versus 
balloon volume data from each heart were fitted to 
a relationship of the form of equation 6 using the 
previously determined values of ~,/3, Ema x, and K. 
Fig. 3, C, shows the postischemic percentage r cov- 
ery of developed pressure versus volume relation- 
ship of a single unprotected heart. 
An average percentage recovery of developed 
pressure was computed for each heart using equa- 
tion 7. The average percentage recoveries were 
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Fig. 4. Average percentage recovery of preischemic de- 
veloped pressure in unprotected hearts (None), in hearts 
protected with hyperkalemic cardioplegia (KCI), and in 
hearts protected with hyperpolarizing cardioplegia 
(Aprikalim). Error bars represent one standard deviation 
of mean. *p < 0.05 compared with None, KC1, **p < 0.05 
compared with None. 
90% _ 9% in hearts protected with hyperpolarizing 
cardioplegia, 73% _ 11% in hearts protected with 
depolarizing cardioplegia, nd 61% ___ 9% in unpro- 
tected hearts (Fig. 4). Hyperpolarizing cardioplegia 
was significantly better than both depolarizing cardio- 
plegia and unprotected global ischemia (p < 0.05). 
Myocardial edema formation. Postischemic tis- 
sue water content determinations demonstrated that 
hearts protected with depolarizing cardioplegia had 
significantly ess edema formation than both hearts 
protected with hyperpolarizing cardioplegia and un- 
protected hearts (Fig. 5) (p < 0.05). 
Discussion 
The cellular adaptation to ischemia. After the 
fast upstroke of the normal cardiac action potential, 
there is a delay before the activation of the delayed 
rectifier current, an outward potassium current hat 
repolarizes the myocyte during the third phase of 
the cardiac action potential s The length of the delay 
is largely responsible for the duration of the plateau 
phase and gives the cardiac action potential its 
characteristic shape and relatively long duration. 8 
Profound shortening of the action potential dura- 
tion occurs rapidly during myocardial ischemia, 32 
anoxia, 33 and metabolic blockade. 34' 35 An increase 
in a time-independent ou ward potassium current is 
responsible for initiating and maintaining action 
potential collapse under these conditions of im- 
paired energy metabolism) 5' 35-37 Collapse of the 
plateau phase of the cardiac action potential short- 
ens the length of time that voltage-gated calcium 
channels are open and therefore decreases calcium 
influx, ultimately resulting in contractile fail- 
ure.33.36, 37 This cascade of events is beneficial dur- 
ing ischemia because suspension of contractile ac- 
tivity decreases metabolic demand, a In addition, the 
reduction of calcium influx ameliorates the sequela 
of myocyte calcium overload, which has been impli- 
cated in the pathogenesis of ischemia/reperfusion 
injury. 2-4 
A specific population of potassium channels inac- 
tivated by intracellular ATP (KAT P channels) is 
responsible for the time-independent outward po- 
tassium current hat shortens the action potential 
duration during ischemia. 15'16'38 These channels 
open during metabolic blockade, 34" 35 anoxia,33 and 
ischemia 32 and on exposure to specific potassium 
channel openers. 38' 39 
KAa- P channels are found in abundance on the cell 
membrane of the myocyte. 4°Open channels have a 
relatively high single-channel conductance of 25 
pS.40, 41 The kinetics of channel opening  myocytes is 
such that half-maximal closure of channels occurs at 
intracellular ATP concentrations i  the range of 20 to 
100 /~mol/t. 35'40'42 However, the normal range of 
intracellular ATP concentrations is 5 to 10 mmol/L. 
Thus, under normal circumstances, virtually all myo- 
cyte KAa- P channels are dosed. Because a high per- 
centage of KA-rp channels remain closed even at 
submillimolar ATP levels, there was initially difficulty 
reconciling the role of KAa- P channels in action poten- 
tial collapse, which occurs almost concomitantly with 
the onset of ischemia nd before the development of a 
significant decline in the level of intracellular ATP. 43 
However, because of th e high membrane density of 
KAa- P channels, the action potential duration is exquis- 
itely sensitive to channel opening and demonstrable 
action potential shortening will occur with nominal 
decreases in intracellular ATP levels. 4°-42' 44, 45 Exper- 
imental evidence has verified theoretic onsiderations 
that predict that opening of less than 1% of all 
available channels would result in a50% reduction of 
action potential duration. 4°-42' 44, 45 
Mechanism of potassium-channel opener-in- 
duced hyperpolarized arrest. Potassium-channel 
openers comprise a diverse group of chemical agents 
Maskal et al. 1091 
90 and include pinacidil, nicorandil, aprikalim, andcro- 
makalim.17, 38-40 The interaction between potassium- 
channel openers, ATP, and KAa- P channels has been 
delineated in cardiac myocytes with use of the Hill 
model of channel opening. 36'37 Potassium-channel 
openers promote channel opening by causing an order 
of magnitude increase in ki, the ATP concentration 
resulting in half maximal closure of KATp channels, 
without changing the steepness ofthe channel opening 
versus ATP concentration relationship. 36 These obser- 
vations suggest hat potassium-channel openers com- 
petitively inhibit binding of ATP at the ATP binding 
site of the channel. 37 
The putative mechanism of potassium-channel 
opener-induced hyperpolarized arrest is that phar- 
macologic dosages of potassium-channel openers 
(twice the maximal effective dose in single cell 
preparations) shift the k i for channel binding of 
ATP into the normal physiologic range of intracel- 
lular ATP concentrations. 14 This simulates a de- 
crease in the effective ATP concentration at the 
intracellular face of the KAT e channel and results in 
channel opening at normal intracellular ATP levels. 
This causes progressive shortening of the action 
potential duration a d, ultimately, action potential 
collapse. Inexcitability and electromechanical quies- 
-ee~F~cc x ,~o~a t .~  I '~II JUICLIIC V~)ILd~C 1~ ~tdOltlZ~O at 
or near the reversal potential for potassium, as a 
direct consequence of the large increase in mem- 
brane permeability opotassium. Potassium-channel 
opener binding is reversible and on reperfusion the 
potassium-channel opener is washed out of the 
coronary circulation. 
The feasibility of potassium-channel opener hy- 
perpolarized arrest. Our laboratory has previously 
demonstrated the feasibility of myocardial protec- 
tion with hyperpolarizing cardioplegic solution con- 
taining the potassium-channel opener, aprikalimJ 4 
These studies were performed in an isovolumic, 
Krebs-Henseleit solution-perfused, rabbit heart 
Langendorff model during a 20-minute interval of 
normothermic, global ischemia. In hearts protected 
with aprikalim cardioplegia, electromechanical 
standstill developed significantly more slowly than in 
hearts protected with standard, hyperkalemic, depo- 
larizing cardioplegia. Nevertheless, postischemic re- 
covery of developed pressure in hearts protected 
with aprikalim cardioplegia was superior to recovery 
in hearts protected with hyperkalemic cardioplegia. 
Furthermore, in contrast o results with hyperkale- 
mic cardioplegia, use of aprikalim cardioplegia did 
not result in a postischemic ncrease in EDP. These 
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Fig. 5. Average tissue water content of unprotected 
hearts (None), hearts protected with hyperkalemic cardio- 
plegia (KCI), and hearts protected with hyperpolarizing 
cardioplegia (Aprikalim). Error bars represent one stan- 
dard deviation fmean. *p < 0.05 compared with None, 
Aprikalim. 
results suggested that aprikalim could ameliorate 
ischemic/reperfusion injury. However, because of 
the disparity between the crystalloid-perfused model 
and the clinical situation, the clinical relevance of 
these findings remained uncertain. This present 
study was undertaken to verify these findings in a 
blood-perfused preparation. 
Preservation of systolic function with potassium- 
channel opener-induced hyperpolarized arrest ver- 
sus hyperkalemic depolarized arrest. Recovery of 
developed pressure after 30minutes of global, nor- 
mothermic ischemia in a parabiotic, blood-perfused 
Langendorff model was significantly better in hearts 
protected with hyperpolarizing cardioplegic solution 
containing aprikalim than in either unprotected 
hearts or hearts protected with hyperkalemic depo- 
larizing cardioplegia. These data confirm our earlier 
results 14 and demonstrate hat aprikalim cardiople- 
gia is cardioprotective in a blood-perfused Langen- 
dorff model. 
Preservation of diastolic function with potassi- 
um-channel opener-induced hyperpolarized arrest 
versus hyperkalemic depolarized arrest. Postisch- 
emic a and/3 coefficients of the exponential EDP- 
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balloon volume relationship did not differ signifi- 
cantly from their respective preischemic values 
either in hearts protected with hyperpolarizing car- 
dioplegia or in hearts protected with depolarizing 
cardioplegia. Thus both types of cardioplegia were 
able to preserve left ventricular diastolic function 
despite the apparently small reduction of myocar- 
dial edema with hyperkalemic, depolarizing cardio- 
plegia. As expected, a significant decrease in ven- 
tricular compliance occurred in unprotected hearts 
subjected to normothermic, global ischemia. 
Cell swelling. Use of hyperkalemic cardioplegic 
solution was associated with a lower tissue water 
content (77.4%) than use of either unprotected 
ischemia (79.4%) or aprikalim cardioplegic solution 
(78.7%). 
Although cell swelling is a recognized complica- 
tion of hyperkalemic ardioplegia, 46 there was 
slightly more myocardial edema formation with 
aprikalim cardioplegia. The vasodilatory properties 
of potassium-channel openers 3s may play a role in 
increasing myocardial edema. Vasodilation of the 
resistance vessels of the coronary vasculature under 
conditions of a fixed perfusion column height will 
effect an increase in coronary flow rate, capillary 
hydrostatic pressure, and, consequently, myocardial 
edema formation. 47 Although delivery times of car- 
dioplegic solutions did not differ between groups in 
this experiment, subsequent, unpublished ata dem- 
onstrate that postreperfusion coronary flow rates 
(measured by an ultrasonic flow probe) in hearts 
protected with hyperpolarizing cardioplegia exceed 
the flow rates in hearts protected with hyperkalemic 
cardioplegia. Therefore aprikalim cardioplegia may 
predispose to the formation of myocardial edema 
during reperfusion. 
Alternatively, the low tissue water content of 
hearts protected with hyperkalemic ardioplegia 
may be artifactual. The membrane depolarization 
associated with hyperkalemic cardioplegia results in 
incomplete sodium channel inactivation and intra- 
cellular sodium accumulation via the sodium "win- 
dow current" during ischemia. 5'6 On reperfusion, 
the accumulated sodium is expelled by the Na+-K ÷- 
ATPase. The electrogenic nature of this pump 
causes anet efflux of water and results in a transient 
contraction of cell volume to less than the original 
control cell volume during reperfusion. This tran- 
sient, ouabain-sensitive c ll volume contraction on 
transfer from hyperkalemic cardioplegic solution to 
normokalemic solution has been documented in 
single rabbit ventricular myocytes. 48Because there 
theoretically is less sodium accumulation during 
ischemia in hearts protected with hyperpolarizing 
cardioplegia, the rebound cell volume contraction 
on reperfusion may be smaller. 
Because the left ventricular tissue water biopsy 
samples in this experiment were obtained after the 
acquisition of the postreperfusion data, it is conceiv- 
able that the observed tissue water content of hearts 
protected with hyperkalemic ardioplegia reflects 
the transient volume contracted state, rather than 
actual edema formation. Left ventricular biopsy 
samples obtained soon after reperfusion would 
more accurately reflect actual edema formation 
during ischemia. However, because of the small size 
of the rabbit heart, this was not feasible. Further 
work in a large-animal model will be needed to 
clarify this phenomenon. 
Regardless of whether differences in myocardial 
edema formation between cardioplegia groups in 
this study were actual or artifactual, the small in- 
crease in observed tissue water content was not 
sufficient o alter the postischemic diastolic proper- 
ties of the left ventricle in hearts protected with 
hyperpolarizing cardioplegia. 
Temporal aspects of the development of electro- 
mechanical arrest with hyperpolarizing versus de- 
polarizing cardioplegia. Ongoing electrical and me- 
chanical activity accelerates the rate of energy 
consumption i the globally ischemic heart. 1 There- 
fore traditional cardioplegic solutions have been 
designed to rapidly induce electromechanical asys- 
tole to optimize myocardial protection. 1 In these 
experiments, mechanical and electrical quiescence 
developed more slowly in hearts protected with 
aprikalim cardioplegia than in hearts protected with 
hyperkalemic cardioplegia, despite comparable de- 
livery times of the cardioplegic solutions. 
In hyperkalemic, depolarized arrest, the car- 
dioplegic solution raises the potassium ion concen- 
tration of the extracellular fluid, which leads to 
membrane depolarization, membrane inexcitability, 
and electrical and mechanical rrest. 1Arrest is rapid 
because potassium ions must only permeate the 
cxtracellular space. By contrast, in potassium-chan- 
nel opener-induced arrest, extreme shortening of 
the action potential duration as a consequence of
KAT e channel opening reduces calcium influx and 
results in contractile failure. 14 However, spikelike 
action potentials persist for several minutes after the 
development of mechanical arrest. 14. 33-36 
Despite the prolongation of mechanical and elec- 
trical activity, potassium-channel opener-induced 
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arrest afforded significantly better preservation of 
left ventricular systolic function than protection with 
hyperkalemic ardioplegia in both our Krebs- 
Henseleit solution-perfused 14 and blood-perfused 
models. This suggests that the cardioprotective prop- 
erties of potassium-channel openers are sufficient o 
offset the energy consumption associated with the 
electrical and mechanical work that occurs before 
quiescence in hearts protected with hyperpolarizing 
cardioplegia. Evidence obtained in an isolated rat 
heart model supports this hypothesis. 13Basal myocar- 
dial oxygen consumption during nonischemic depolar- 
ized arrest has been shown to be 50% greater than the 
oxygen consumption during nonischemic hyperpolar- 
ized arrest in rat hearts, a3 This difference was attrib- 
uted to increased myocardial wall tension caused by 
the increased intracellular calcium concentration i
hearts undergoing depolarized arrest. The large de- 
crease in basal energy consumption associated with 
nondepolarized arrest could easily compensate for the 
excess energy consumption associated with the persis- 
tent electrical activity, because the generation of elec- 
trical activity comprises less than 1% of the total basal 
oxygen consumption of the heart. 49 
Proarrhythmic sequelae of potassium-channel 
openers. Potassium-channel openers increase the 
~sion  ~,i-¢ *~t*a~t~,xn*~ and ~nult~n/t~na~tOl~i- 
ness in myocardial tissue. 5° They have been shown 
to be proarrhythmic for reentrant arrhythmias, 
which commonly occur in the setting of ischemia/ 
reperfusion. 5° However, in this experiment, there 
was no statistically significant difference in the rates 
of occurrence of ventricular fibrillation on reperfu- 
sion among the three groups. Furthermore, arrhyth- 
mias occurred only on reperfusion, were easily 
cardioverted, and did not recur after initial cardio- 
version. Thus they did not present a significant 
experimental problem. 
Vasodilatory effects of potassium-channel open- 
ers. Clinical use of potassium-channel opener-in- 
duced hyperpolarized arrest may be limited by the 
profound systemic vasodilation and hypotension 
that develop when pharmacologic dosages of potas- 
sium-channel openers are administered systemical- 
ly. 38 This effect is a result of the presence of KAT P 
channels in the smooth muscle of the arterial vas- 
culature. 3s In this experiment, measures were taken 
to avoid circulation of the spent cardioplegic solu- 
tion to the support abbit. Similar precautions would 
need to be taken in the clinical setting. 
Unfortunately, currently available potassium- 
channel openers are more potent openers of vascu- 
lar smooth muscle KAT P channels than of myocyte 
KAT P channels. 38 This suggests the existence of 
tissue-specific differences in KAT P channel structure. 
Once KAT P channels are cloned and their primary, 
secondary, and tertiary structures elucidated, the 
differences between cardiac and vascular smooth 
muscle channels can potentially be exploited to 
develop cardioselective potassium-channel openers. 
Advantages and disadvantages of the parabiotic, 
blood-perfused model. The main disadvantage of 
the parabiotic model is the loss of the ability to exert 
absolute control over the perfusate composition, as 
is possible in a crystalloid-perfused Langendorff 
model. In the parabiotic model, only a relative 
degree of control over the pH, hematocrit value, 
osmolality, and ion concentration is possible. Fur- 
thermore, temporal changes in circulating catechol- 
amine levels in the support animal can confound 
evaluation of the postischemic functional recovery 
of the isolated heart. However, continuous, careful 
monitoring of the level of support-animal nesthesia 
will minimize fluctuations in support-animal cate- 
cholamine levels. 
The more physiologic nature of the parabiotic, 
blood-perfused model favors its use over the crys- 
talloid-perfused model. The blood-perfused model 
inure closely resembles the clinical situation.~There- 
fore results obtained from this model will assume 
greater clinical relevance than results obtained in a 
crystalloid-perfused model. 
The absence of hemoglobin greatly limits the 
oxygen-carrying capacity of crystalloid solutions and 
necessitates supranormal coronary flow rates in 
crystalloid-perfused models to support normal cel- 
lular respiration. 24'51 As a consequence of the 
higher flow rates with crystalloid perfusate, capillary 
hydrostatic pressure will be elevated. 24' 51 Further- 
more, owing to an absence of plasma proteins, 
crystalloid perfusate xerts a lower oncotic pressure 
than blood perfusate. 52The combination of a lower 
perfusate oncotic pressure and elevated capillary 
hydrostatic pressure will shift the normal equilib- 
rium of Starling forces and lead to increased edema 
formation with a crystalloid perfusate. 24
The buffering capacity of blood is far superior to 
that of crystalloid perfusate because of the presence 
of a large number of hydrogen ion-binding histidine 
residues in hemoglobin and plasma proteinsY -27 
Furthermore, the action of erythrocyte carbonic 
anhydrase permits the erythrocyte to extract hydro- 
gen ions from the tissues to buffer tissue pH at the 
expense of erythrocyte pH. 27 Finally, use of crystal- 
1094 Mas~letaL 
The Journal of Thoracic and 
Cardiovascular Surgery 
October 1995 
loid perfusate may have unanticipated rheologic 
implications, such as the alteration of capillary flow 
distribution because of shunting of flow. 27' 29 All of 
these factors are important in the investigation of 
ischemia/reperfusion phenomena and make the 
blood-perfused model preferable. 
Summary. These experiments have demon- 
strated that myocardial protection with hyperpolar- 
izing cardioplegic solution containing aprikalim is 
superior to standard hyperkalemic, depolarized ar- 
rest in a blood-perfused isolated heart model. De- 
spite the prolonged electrical activity associated with 
its use, aprikalim cardioplegia was superior to hy- 
perkalemic cardioplegia at preserving ventricular 
systolic function during normothermic global isch- 
emia. Furthermore, our data suggest that use of 
aprikalim cardioplegia is not associated with a post- 
ischemic decrease in left ventricular compliance ven 
though there was a slight increase in myocardial 
edema formation. Our data support the hypothesis 
that hyperpolarized cardiac arrest is a more advanta- 
geous form of myocardial preservation than traditional 
depolarized arrest. To determine the clinical feasi- 
bility of potassium-channel opener- induced arrest, 
future studies are needed in an intact animal model. 
We would like to acknowledge the technical assistance 
of Cynthia Allen, BA. 
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